Lawrence Klein - Oct 15, 2021 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role
CBO & COO
Signature
/s/ Michael Esposito, attorney-in-fact
Stock symbol
CRSP
Transactions as of
Oct 15, 2021
Transactions value $
$0
Form type
4
Date filed
10/18/2021, 08:00 PM
Previous filing
Oct 1, 2021
Next filing
Dec 7, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRSP Stock Option (Right to Buy) Award $0 +13.8K $0.00 13.8K Oct 15, 2021 Common Shares 13.8K $97.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on October 15, 2021 with respect to 13,800 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 15, 2021.